|
Verzögert
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 77.36 USD | +0.86% |
|
-5.47% | -2.00% |
Hauptkonkurrenten
| Umsatz (Y-1) | Nettogewinn (Y-1) | EBIT-Marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 614 Mio. | -3.28% | 0.1% | - | - | - | ||
| 65.18 Mrd. | 31.67% | 41.84% | 103.86% | 22.92% | 0.95x | ||
| 94.19 Mrd. | 28.46% | 32.23% | 34.62% | 14.26% | 0.73x | ||
| 56.33 Mrd. | 7.59% | 41.43% | 263.08% | 13.34% | 2.56x | ||
| 77.58 Mrd. | 20.94% | 35.49% | 47.65% | 15.43% | 0.66x | ||
| 54.07 Mrd. | 13.01% | 31.31% | 32.11% | 12.51% | 1.47x | ||
| 56.67 Mrd. | 24.64% | 38.62% | 38.4% | 16.33% | 1.02x | ||
| 64.17 Mrd. | 26.68% | 36.46% | 46.35% | 17.38% | 0.86x | ||
| 48.59 Mrd. | 33.14% | 41.3% | 60.7% | 20.31% | 0.69x | ||
| 33.42 Mrd. | 12.24% | 44.96% | 177.29% | 11.36% | 2.33x | ||
| 28.75 Mrd. | 1.67% | 29.63% | 27.6% | 9.57% | 1.48x | ||
| 63.63 Mrd. | 12.62% | 34.24% | 19.99% | 8.05% | 1.52x | ||
| 12 Mrd. | 32.94% | 43.85% | 27.07% | 16.41% | -1.18x | ||
| 48.19 Mrd. | 14.64% | 30.37% | 72.08% | 7.72% | 1.83x | ||
| 39.28 Mrd. | 8.21% | 29.16% | 48.09% | 10.97% | 1.22x | ||
| 42.53 Mrd. | 13.98% | 27.61% | 11.75% | 4.43% | 0.68x | ||
| 7.45 Mrd. | 33.09% | 46.3% | 22% | 18.71% | -1.74x | ||
| 30.6 Mrd. | 2.36% | 7.48% | 1.5% | 1.19% | 3.6x | ||
| 3.83 Mrd. | 22.64% | 26.77% | 14.73% | 13.49% | -2.98x | ||
| 48.25 Mrd. | -5.48% | 11.66% | 15.32% | -2.25% | 3.2x | ||
| Durchschnitt | 43.77 Mrd. | 16.59% | 31.54% | 56.01% | 12.22% | 0.99x | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 58.39 Mrd. | 21.45% | 36.46% | 75.61% | 15.26% | 1.08x |
- Börse
- Aktien
- A1W15D Aktie
- Sektor ANI Pharmaceuticals, Inc.
- Finanzielle Vergleiche
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















